Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,014 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

NCT01174732

Conditions
Asthma, Bronchial Diseases, Bronchial Spasm, +13 more
Locations
  • Amphastar Site 0001 San Jose, California, United States
  • Amphastar Site 0007 Centennial, Colorado, United States
  • Amphastar Site 0008 Denver, Colorado, United States
  • Amphastar Site 0039 Lakewood, Colorado, United States
View Trial Details
Completed

Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD

NCT02055352

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site Florida, Buenos Aires, Argentina
  • Novartis Investigative Site La Plata, Buenos Aires, Argentina
View all 25 locations
View Trial Details
Completed

Life-long Monitoring of COPD in Veneto Region

NCT01513980

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Local Health Autority n.16 Padova - Pulmonology outpatient clinic Padova, Italy
  • Hospital Trust of Padova - Respiratory Physiopathology Department Padova, Italy
  • Ospedale Ca'Foncello - Pulmonology Department Treviso, Italy
  • Ospedale dell'Angelo - Pulmonology Department Mestre, Venezia, Italy
View Trial Details
Completed

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

NCT01443845

Conditions
COPD, COPD Exacerbation, Chronic Disease, +12 more
Locations
  • Forest Investigative Site 081 Anniston, Alabama, United States
  • Forest Investigative Site 065 Athens, Alabama, United States
  • Forest Investigative Site 131 Florence, Alabama, United States
  • Forest Investigative Site 073 Mobile, Alabama, United States
View all 338 locations
View Trial Details
Completed

Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients

NCT02125734

Conditions
COPD, Chronic Disease, Chronic Obstructive Pulmonary Disease, +7 more
Locations
  • Novartis Investigative Site Ibbenbüren, Rhineland-Palatinate, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Bonn, Germany
View all 18 locations
View Trial Details
Completed

Dose Finding Study of CHF 4226 for Treating Patients With COPD

NCT00605891

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Clopton Clinic Jonesboro, Arkansas, United States
  • ABM Research Center Fresno, California, United States
  • UCSD - Clinical Trials Center San Diego, California, United States
  • Institute of Healthcare Assessment Inc. San Diego, California, United States
View all 50 locations
View Trial Details
Completed

Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

NCT01425814

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#5 Berlin, Germany
  • Almirall Investigational Sites#2 Berlin, Germany
  • Almirall Investigational Sites#6 Frankfurt, Germany
  • Almirall Investigational Sites#3 Großhansdorf, Germany
View Trial Details

Related conditions